About NIA

Fiscal Year 2008 Budget

Narrative by Program

Biology of Aging Program:
Understanding Aging Processes, Health, and Longevity

Investigators supported by NIA's Biology of Aging Program (BAP) seek to better understand the basic biochemical, genetic, and physiological mechanisms that underlie the process of aging and age-related changes in humans and in animal models. BAP supports research on age-related changes in structure and function, from the molecular and cellular level to entire organisms, as well as the ways in which these changes are related to diseases and conditions common to aging. This program supports integrated research on genetics and other aspects of aging-related changes in multiple model systems, including both mammals and non-mammalian organisms (e.g. flies, worms, and yeast).

Budget Policy: The 2008 budget estimate for the Biology of Aging Program is $175,672,000, an increase of $72,000 or 0.04 percent from the FY 2007 Continuing Resolution of $175,600,000. Program objectives for FY 2008 include plans to:

  • Continue the search for interventions that extend the lifespan. The recent finding that resveratrol could affect the health and survival of mammals exemplifies the promise of this research. An important component in this area is the Intervention Testing Program, which supports the testing of compounds with the potential to extend the lifespan and delay disease and dysfunction in a mouse model. Plans are to renew this promising initiative in FY 2007 for funding in FY 2008.
  • Continue to search for genes and biological pathways that influence longevity and aging. NIA's primary mechanism for this endeavor is the Longevity Associated Gene initiative, which to date has identified over one hundred new longevity-associated genes, along with many conserved biological processes and pathways that regulate longevity in a host of divergent species, including humans.
  • Increase our understanding of the aging immune system. A new initiative on "Membrane Associated Signaling Defects in Immune Cells with Aging" seeks to shed light on the cellular processes that may lead to impaired immune function in older people.
  • Understand the role of nuclear receptors in aging. Research supported under two complementary program announcements will focus on the biologic mechanisms that underlie the activity of nuclear receptors, which are molecules that play key roles in various physiologic and pathophysiologic processes, including those involved in aging and in age-related diseases.
  • Continue the highly successful Nathan Shock Centers of Excellence in Basic Biology of Aging. These centers enhance the ability of institutions with well-developed research programs in basic research on aging to use state-of-the-art research resources to provide the strongest environment for the conduct of research on aging.

Behavioral and Social Research Program:
Understanding and Addressing the Behavioral, Emotional, and Social Dynamics of Aging

NIA Behavioral and Social Research Program (BSR) supports social and behavioral research to better understand the processes of aging at both the individual and societal level. Research areas include the behavioral, emotional, and social changes individuals undergo throughout the adult lifespan; interrelationships between older people and social institutions; and the societal impact of the changing age composition of the population. BSR also supports research training, development of research resources, and a knowledge base for the development of interventions to maximize active life and health expectancy.

Budget Policy: The 2008 budget estimate for the Behavioral and Social Research Program is $168,850,000, an increase of $70,000 or 0.04 percent from the FY 2007 Continuing Resolution of $168,780,000. Program plans for FY 2008 are to:

  • Initiate a new wave of the National Long-Term Care Survey (NLTCS) and continue other major demographic studies. The NLTCS is a longitudinal survey to study changes in the health and functional status of older Americans and track health expenditures; Medicare services used; and the availability of personal, family, and community resources for caregiving. It is considered one of the most useful resources for analyzing national disability trends. Other important ongoing studies include the Health and Retirement Survey and collaborations with the Census Bureau and the Federal Forum on Aging.
  • Support research initiatives to address financial challenges faced by American elders. Funding for two major initiatives in this area will run through FY 2008. One initiative, "Developing Integrated Economic Models of Health Retirement," will stimulate development of comprehensive econometric models of retirement from the labor force. The other focuses on the neuroeconomics of aging and supports research to examine the social, emotional, cognitive, motivational processes and neurobiological mechanisms of decision-making behavior in older people.
  • Support research on ways in which data from ongoing clinical trials and other studies can be used to plan and prepare for future natural and man-made disasters. Three coordinated research solicitations focused on behavioral and social aspects of disasters were released in 2006 to stimulate research on the consequences of natural and man-made disasters and their effects on the health of vulnerable groups, with the ultimate goal of preventing and/or mitigating harmful consequences.

Neuroscience and Neuropsychology of Aging:
Understanding, Preventing, and Treating Cognitive Decline and Disability

NIA's Neuroscience and Neuropsychology of Aging (NNA) Program supports a broad spectrum of research and training aimed at better understanding age-related normal and pathological changes in the structure and function of the nervous system and how such changes affect behavior. The basic mission is to expand knowledge on the aging nervous system to allow improvement in the quality of life of older people. This includes basic and clinical studies of the nervous system, clinical trials of treatments and preventive interventions for neurological disease, and epidemiological research to identify risk factors and to establish prevalence and incidence estimates of pathologic conditions. Additionally, it supports research relevant to those geriatric problems arising from psychiatric and neurologic disorders associated with aging.

Budget Policy: The 2008 budget estimate for Neuroscience and Neuropsychology of Aging Program is $413,131,000, an increase of $171,000 or 0.04 percent from the FY 2007 Continuing Resolution of $412,960,000. Program plans for FY 2008 are to:

  • Continue to support high-quality research on Alzheimer's disease (AD). Alzheimer's disease is a major public health issue for the United States because of its enormous impact on individuals, families, the health care system, and society as a whole. NIA supports a robust portfolio that encompasses all areas of AD research, from the disease's molecular underpinnings to cutting-edge diagnostic and treatment modalities. NIA will continue a comprehensive drug development program and pilot trials initiative plus a cooperative agreement with the University of California, San Diego to conduct several new clinical trials of interventions to treat AD through the Alzheimer's Disease Cooperative Study. (See the "program portrait.")
  • Support research on maintenance of cognitive and emotional health into older age. NIA joined with the National Institute of Mental Health and the National Institute on Neurological Disorders and Stroke to launch the Cognitive and Emotional Health Project, which is designed to assess the state of longitudinal and epidemiological research on demographic, social, and biologic determinants of cognitive and emotional health in aging adults and the pathways by which cognitive and emotional health may reciprocally influence each other. A "Cognitive Health Summit" planned for Spring 2007 will inform future research in this area.
  • Develop new tools, resources, and training opportunities to accelerate the pace of discovery in neuroscience research through participation in the NIH Blueprint for Neuroscience Research. NIA is one of fifteen NIH Institutes that participate in the Blueprint, designed to enhance collaboration through coordinated initiatives. The first Blueprint initiatives began in FY 2005. The priority in FY 2007 is neurodegeneration with neurodevelopment the priority in FY 2008.
  • Continue research on neurological diseases and conditions other than AD that occur in older Americans, including Parkinson's disease, frontotemporal dementia (FTD), and amyotrophic lateral sclerosis (ALS). This research is an important component of NIA's portfolio. NIA-supported researchers recently identified a misfolded protein that is common to FTD and ALS, which provides important insights about the mechanisms of both diseases.

Program Portrait: Alzheimer's Disease Research
FY 2007 level: $503,160,000
FY 2008 level: $503,660,000
Change: $ 500,000

Alzheimer's disease (AD) is the most common cause of dementia among people age 65 and older. Scientists estimate that as many as 4.5 million Americans suffer with the disease, and this number is expected to increase almost three-fold by 2050. (5) Research into the causes, detection, diagnosis, treatment, and prevention of AD is a major priority for the National Institute on Aging (NIA). In fact, since its inception in 1974, NIA has dedicated the majority of its research budget to the study of AD and AD-related processes.

NIA supports AD-related research through both investigator-initiated projects and targeted initiatives such as the Alzheimer's disease Neuroimaging Initiative(ADNI), a five-year study that is the most comprehensive effort to date to identify brain and other biological changes associated with memory decline. The goal of the AD Genetics Initiative advances the search for genes associated with AD. A large, widely-available bank of genetic material, cell lines, and data from families with multiple members with late-onset AD has accelerated NIA's efforts to identify these genes. Discovery of risk factor genes will help illuminate the underlying disease processes of AD, open up novel areas of research, and identify new targets for drug therapy. NIA also launched a major AD drug discovery effort, complemented by a pilot clinical trials program. This research initiative seeks to stimulate preclinical research in the discovery, design, development and testing of novel compounds aimed at slowing, halting, or even reversing the progressive decline in cognitive function and modifying the behavioral symptoms in

Alzheimer's disease as well as delaying the onset of or preventing AD. In addition, the institute currently supports some 25 AD clinical trials. Finally, NIA facilitates the dissemination of the latest information about AD through its Alzheimer's Disease Education and Referral (ADEAR) center, which has provided accurate, up-to-date information concerning AD to health professionals, people with AD and their families, and the general public since 1990. These
activities, along with NIA's ongoing program of investigator-initiated research in AD, will continue through FY 2008.

In October 2006, NIA held a major scientific meeting to discuss future directions for the NIH Alzheimer's disease research agenda, with particular attention to research issues that need to be addressed in order to improve diagnosis and treatment of AD. This meeting brought together internationally-recognized experts in the field, and the results will inform NIA's research agenda in AD over the next few years.

Geriatrics and Clinical Gerontology Program:
Reducing Disease and Disability Among Older People

As we age, our risk for many other types of disease and/or disability increases dramatically. NIA's Geriatrics and Clinical Gerontology (GCG) Program supports research on health, disease, and disability in the aged (other than neurodegeneration, which is the focus of the NNA Program). Areas of focus include age-related physical changes and their relationship to health outcomes, the maintenance of health and the development of disease, and specific age-related risk factors for disease. The program also plans and administers clinical trials.

Budget Policy: The 2008 budget estimate for the Geriatrics and Clinical Gerontology Program is $135,148,000, an increase of $55,000 or 0.04 percent from the FY 2007 Continuing Resolution of $135,093,000. Program objectives for FY 2008 include plans to:

  • Initiate studies of venous and arterial thrombosis in the elderly. Advanced age is associated with a dramatic increase in venous and arterial thrombosis (the development of dangerous blood clots in the veins and arteries). However, the biologic mechanisms for this increased risk are poorly understood. A new initiative will explore the biological mechanisms, epidemiology, pathophysiology, and clinical aspects (diagnosis, treatment, and prevention) of this common condition.
  • Continue clinical trials of the efficacy and safety of testosterone in older men for a variety of conditions. Two trials are targeted to begin in mid-2007 -- one for men over 65 and one for younger men. The trials are expected to run for approximately six years. Participants will include men who are experiencing clinical symptoms related to low testosterone levels. Although these are treatment studies, the results may inform future prevention trials.
  • Continue research on anemia in the elderly. Anemia is common among older people; however, over halfthe cases of anemia in older adults occur without a clearly identifiable cause. An ongoing program supports research to better understand the epidemiology, pathophysiology, and clinical aspects of anemia in the elderly. Findings from this research may prove critical to the development of clinical trials.

(5) Hebert, op. cit.